Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: A novel class of potential antibacterial and antitubercular agents

European Journal of Medicinal Chemistry

Volumn 43, Issue 9, 2008, Pages 1989-1996

  Joshi, S D ^b   Vagdevi, H M ^a   Vaidya, V P ^a   Gadaginamath, G S ^b  

^a KUVEMPU UNIVERSITY   (India)

^b S E T S COLLEGE OF PHARMACY   (India)

Author keywords

Acid hydrazide derivatives; Antibacterial activity; Antitubercular activity; Broth dilution assay method; Pyrroles

Indexed keywords

4 PYRROL 1 YL BENZOIC ACID HYDRAZIDE DERIVATIVE; CIPROFLOXACIN; HYDRAZIDE DERIVATIVE; ISONIAZID; NORFLOXACIN; OXADIAZOLE DERIVATIVE; PYRROLE DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BROTH DILUTION; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MYCOBACTERIUM TUBERCULOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; REACTION ANALYSIS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; BENZOIC ACID; DRUG DESIGN; MYCOBACTERIUM TUBERCULOSIS; OXADIAZOLES; PYRROLES; TRIAZOLES;

EID: 51149107005     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.11.016     Document Type: Article

References (28)

1. Duncan K. Chem. Ind. (1997) 861
2. Demirayak S., Karaburun A.C., and Kiraz N. Eur. J. Med. Chem. 34 (1999) 275-278
3. Halazy S., and Magnus P. Tetrahedron Lett. 25 (1984) 1421
4. Li B., Zhang Z., and Goadeng X. Huexiao Huaxue Xuebao 6 (1985) 917
5. Bijev A. Arzneim.-Forsch/Drug Res. 56 (2006) 96-103
6. Sbardella G., Mai A., Artico M., Loddo R., Setzuc M.G., and Collac P.L. Bioorg. Med. Chem. Lett. 14 (2004) 1537-1541
7. C. Brikner, S. Leyck, B. Christ, K. Kesselring, German Patent 3, 506, 1986.
8. Jones R.A., and Bean G.P. The Chemistry of Pyrroles (1997), Academic Press, London
9. Jones R.A. Pyrroles, Part II: The Chemistry of Heterocyclic Compounds (1992), Wiley, New York
10. Sriram D., Yogeeswari P., and Madhu K. Bioorg. Med. Chem. Lett. 16 (2006) 876-878
11. Mir I., Siddique M.T., and Comeic A. Tetrahedron 26 (1970) 5235
12. Burch H.A., and Smith W.O. J. Med. Chem. 9 (1966) 405
13. Berk B., Aktay G., Yesilada E., and Ertan M. Pharmazie 56 (2001) 613
14. Hassan E., Al-Ashmawi M.I., and Abdel-Fattah B. Pharmazie 38 (1983) 833-835
15. Khalil M.A., El-Sayed O.A., and El-Shamny H.A. Arch. Pharm. 326 (1993) 489-492
16. M.J. Hearn, PCT Int. Appl. WO 02043668, 2002.
17. Chem. Abstr. 137 (2002) 20296
18. Shah R.R., Mehta R.D., and Parikh A.R. J. Indian Chem. Soc. 62 (1985) 255
19. Colautti A., Ferlauto R.J., Maurich V., De Nardo M., Nisi C., Rubessa F., and Runti C. Chim. Ther. 6 (1971) 367
20. Wu Q., Mao S., Mu C., Yang H., and Qim Z. Nongyaoxue Xuebao 4 (2002) 70
21. Chem. Abstr. 138 (2003) 304202
22. Vigorita M.G., Maccari R., Ottana R., and Monforte F. Med. Chem. Res. 9 (1999) 306
23. Desai N.C., Shukla H.K., and Thaker K.A.J. J. Indian Chem. Soc. 61 (1984) 239
24. Goto S., Jo K., Kawakita T., Mitsuhashi S., Nishino T., Ohsawa N., and Tanami H. Chemotherapy 29 (1981) 76-79
25. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility for Bacteria Grown Aerobically, Approved Standard (1985), National Committee for Clinical Laboratory Standards, Villanova, PA
26. Suling W.J., Seitz L.E., Pathak V., Westbrook L., Barrow E.W., Ginkel S.Z.V., Reynolds R.C., Robert Piper J., and Barrow W.W. Antimicrob. Agents Chemother. 44 (2000) 2784-2793
27. Yajko D.M., Madej J.J., Lacaster M.V., Sanders C.A., Cawthon V.L., Gee B., Babst A., and Keith Hardley W. J. Clin. Microbiol. 33 (1995) 2324
28. Jones R.A. Aust. J. Chem. 19 (1966) 289